Marijuana Rescheduling Could ‘Unlock Research’ To Treat Rare Diseases, Father Of Terminally Ill Child Tells Congressional Committee
A father of a terminally ill child testified before the House Small Business Committee in favor of marijuana rescheduling, arguing it could unlock research to treat rare diseases. The hearing also addressed broader policy challenges related to cannabis therapeutic access and federal scheduling reform.
Filed under Federal Action in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
Anti-Marijuana Groups File Lawsuit To Block Trump Administration’s Hemp CBD And THC Medicare Coverage Plan
AOC Slams Federal Drug Laws That Restrict Marijuana And Psychedelics Despite Their Medical Value
Keith Ellison, 38 other attorneys general ask Congress to ban intoxicating hemp products
Trump puts medical cannabis protections in budget (Newsletter: April 6, 2026)
Feds sued over Medicare cannabis product coverage (Newsletter: April 1, 2026)
Ellison and other AGs push for ban on ‘intoxicating hemp-derived’ THC products
Stay current on Minnesota cannabis
Browse more federal action updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.